Lee CH, Mak LY, Tang EH, Lui DT, et al. SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong. Hepatology 2023;78:1569-1580.
PMID: 37055020